Results 91 to 100 of about 8,842 (142)

The Saudi National Policy and Protocol for Epidermolysis Bullosa. [PDF]

Risk Manag Healthc Policy
Alheggi A, Alhashem A, Alshihry HMH, Al-Khenaizan S, Alshammrie FF, AlEissa MM, Almudaiheem HY, Shehata N, Alshingetti N, Almudeer AH, Alshammari IF, Alsefri MF, Al-Jedai A, Eshmawi MT.   +13 more
europepmc   +1 more source

Clinical and molecular spectrum of inherited epidermolysis bullosa in a Thai cohort: A 12-year retrospective study. [PDF]

JAAD Int
Supsrisunjai C, Tirachaimongkol N, Bunnag T, Sengtae N, Tongsima S, Ngamphiw C, Komkhong W, Kootiratrakarn T, Wessagowit V, Kantaputra P.   +9 more
europepmc   +1 more source

Patient-reported outcomes during pregnancy and delivery in epidermolysis bullosa. [PDF]

BMC Pregnancy Childbirth
Zott A, Diem A, Prodinger C, Ude-Schoder K, Bauer JW, Welponer T, Laimer M.   +6 more
europepmc   +1 more source

The Therapeutic Challenge in a Rare Case of Immunoglobulin A Type of Epidermolysis Bullosa Acquisita.

Indian J Dermatol
Gowda SK, Behera B, Sethy M, Ayyanar P.
europepmc   +1 more source

A Case of Neonatal Junctional Epidermolysis Bullosa With a LAMB3 Mutation: Diagnostic Journey and Interdisciplinary Management. [PDF]

Case Rep Pediatr
Tete PI, D S A, Rafi M, B J S.
europepmc   +1 more source

Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies. [PDF]

Drugs
du Rand A, Buttle B, Sheppard H.
europepmc   +1 more source

In vivo confocal microscopic evaluation of patients with epidermolysis bullosa demonstrates severe loss of corneal nerves. [PDF]

Am J Ophthalmol Case Rep
Saricay LY, Fidan DG, Galinko S, Huynh E, Thompson A, Chen VM, Hamrah P.   +6 more
europepmc   +1 more source

Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients. [PDF]

Orphanet J Rare Dis
Amsalu A, Haidari H, Mirco B, Rudolph-Stringer V, Walter S, Antipov A, Murrell DF, Kopecki Z.   +7 more
europepmc   +1 more source

Long-term survival in severe epidermolysis bullosa simplex with the potentially fatal <i>KRT5</i> p.Glu477Lys variant. [PDF]

JAAD Case Rep
Rayinda T, Ferronika P, Pungky A, Asifa NN, Danarti R.   +4 more
europepmc   +1 more source